These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11182752)

  • 21. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release.
    Leskinen H; Vuolteenaho O; Leppäluoto J; Ruskoaho H
    Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GH-releasing peptide-6 overcomes refractoriness of somatotropes to GHRH after feeding.
    McMahon CD; Chapin LT; Radcliff RP; Lookingland KJ; Tucker HA
    J Endocrinol; 2001 Jul; 170(1):235-41. PubMed ID: 11431156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release.
    Torsello A; Luoni M; Schweiger F; Grilli R; Guidi M; Bresciani E; Deghenghi R; Müller EE; Locatelli V
    Eur J Pharmacol; 1998 Nov; 360(2-3):123-9. PubMed ID: 9851578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.
    Wu D; Chen C; Zhang J; Bowers CY; Clarke IJ
    J Endocrinol; 1996 Feb; 148(2):197-205. PubMed ID: 8699133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
    Fairhall KM; Mynett A; Robinson IC
    J Endocrinol; 1995 Mar; 144(3):555-60. PubMed ID: 7738479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone-releasing peptides.
    Ghigo E; Arvat E; Muccioli G; Camanni F
    Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced food intake after stimulation of hypothalamic P2Y1 receptors in rats: modulation of feeding behaviour by extracellular nucleotides.
    Kittner H; Franke H; Harsch JI; El-Ashmawy IM; Seidel B; Krügel U; Illes P
    Eur J Neurosci; 2006 Oct; 24(7):2049-56. PubMed ID: 17067301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes.
    Torsello A; Locatelli V; Melis MR; Succu S; Spano MS; Deghenghi R; Müller EE; Argiolas A
    Neuroendocrinology; 2000 Dec; 72(6):327-32. PubMed ID: 11146415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute dexamethasone administration enhances GH responsiveness to GH releasing peptide-6 (GHRP-6) in man.
    Pinto AC; Finamor FE; Lengyel AM
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):409-14. PubMed ID: 10583306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH-releasing hexapeptide in normal adult subjects.
    Popovic V; Pekic S; Simic M; Damjanovic S; Micic D; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):89-94. PubMed ID: 11849251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term administration of L-arginine, L-NAME, and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats.
    Böger RH; Bode-Böger SM; Gerecke U; Frölich JC
    Cardiovasc Res; 1994 Apr; 28(4):494-9. PubMed ID: 8181036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of GHRP-6 and GHRH on GH secretion in rats following chronic glucocorticoid treatment.
    Voltz DM; Piering AW; Magestro M; Giustina A; Wehrenberg WB
    Life Sci; 1995; 56(7):491-7. PubMed ID: 7869829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microinjection of the nitric oxide synthase inhibitor L-NAME into the lateral basal forebrain alters the sleep/wake cycle of the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):239-47. PubMed ID: 14751418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of NG-nitro-L-arginine methyl ester, the nitric oxide synthase inhibitor, on duodenal alkaline secretion and mepirizole-induced duodenal lesions in rats.
    Takeuchi K; Takehara K; Kato S
    J Clin Gastroenterol; 1995; 21 Suppl 1():S66-72. PubMed ID: 8774993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD; Friberg P; Adams MA
    J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
    Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2) in rat anterior pituitary cells.
    Akman MS; Girard M; O'Brien LF; Ho AK; Chik CL
    Endocrinology; 1993 Mar; 132(3):1286-91. PubMed ID: 8095015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.